ATRAID regulates the action of nitrogen-containing bisphosphonates on bone
2020; American Association for the Advancement of Science; Volume: 12; Issue: 544 Linguagem: Inglês
10.1126/scitranslmed.aav9166
ISSN1946-6242
AutoresLauren E. Surface, Damon T. Burrow, Jinmei Li, Jiwoong Park, Sandeep Kumar, Cheng Lyu, Niki Song, Zhou Yu, Abbhirami Rajagopal, Yangjin Bae, Brendan Lee, Steven Mumm, C. Charles Gu, Jonathan C. Baker, Mahshid Mohseni, Melissa Sum, Margaret Huskey, Shenghui Duan, Vinieth N. Bijanki, Roberto Civitelli, Michael J. Gardner, Chris M. McAndrew, William M. Ricci, Christina A. Gurnett, K Diemer, Fei Wan, Christina L. Costantino, Kristen Shannon, Noopur Raje, Thomas B. Dodson, Daniel A. Haber, Jan E. Carette, Malini Varadarajan, Thijn R. Brummelkamp, Kıvanç Birsoy, David M. Sabatini, Gabe Haller, Timothy R. Peterson,
Tópico(s)Boron Compounds in Chemistry
ResumoATRAID is essential for responses to the commonly prescribed osteoporosis drugs nitrogen-containing bisphosphonates.
Referência(s)